ESAIY
Price:
$8.34
Market Cap:
$1.45T
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-02-02
Stock Exchange
PNK
Ticker
ESAIY
According to Eisai Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 3.79%. This represents a change of 298.94% compared to the average of 0.95% of the last 4 quarters.
The mean historical ROE of Eisai Co., Ltd. over the last ten years is 8.53%. The current 3.79% ROE has changed -55.60% with respect to the historical average. Over the past ten years (40 quarters), ESAIY's ROE was at its highest in in the June 2022 quarter at 3.50%. The ROE was at its lowest in in the March 2022 quarter at -1.73%.
Average
8.53%
Median
6.92%
Minimum
5.07%
Maximum
17.83%
Discovering the peaks and valleys of Eisai Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.01%
Maximum Annual ROE = 17.83%
Minimum Annual Increase = -65.00%
Minimum Annual ROE = 5.07%
Year | ROE | Change |
---|---|---|
2024 | 5.07% | -25.51% |
2023 | 6.81% | -1.62% |
2022 | 6.92% | 10.84% |
2021 | 6.24% | -65.00% |
2020 | 17.83% | 77.01% |
2019 | 10.07% | 20.18% |
2018 | 8.38% | 20.98% |
The current ROE of Eisai Co., Ltd. (ESAIY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.26%
5-year avg
8.57%
10-year avg
8.53%
Eisai Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eisai Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eisai Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eisai Co., Ltd.'s ROE?
How is the ROE calculated for Eisai Co., Ltd. (ESAIY)?
What is the highest ROE for Eisai Co., Ltd. (ESAIY)?
What is the 3-year average ROE for Eisai Co., Ltd. (ESAIY)?
What is the 5-year average ROE for Eisai Co., Ltd. (ESAIY)?
How does the current ROE for Eisai Co., Ltd. (ESAIY) compare to its historical average?